LENZ Therapeutics, Inc., a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve near vision in people with presbyopia, announced that the Company will host a Key Opinion Leader event on Tuesday, June 18, 2024 at 8:00 a.m. ET.
June 10, 2024
· 3 min read